Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kanfer

Showing results (361-370 of 374) with videos related to

Pageof 38
Sort By:
Frontiers in Cellular and Infection Microbiology|September 13, 2021
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell TransplantationAndrew J Innes, Benjamin H Mullish, Rohma Ghani, et al.
Bone Marrow Transplantation|April 17, 2021
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMTToby A Eyre, Sophie Caillard, Herve Finel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantationPaula Garland, Hugues de Lavallade, Takuya Sekine, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Pharmaceutical Research|January 8, 2014
Current challenges in bioequivalence, quality, and novel assessment technologies for topical productsAvraham Yacobi, Vinod P Shah, Edward D Bashaw, et al.
British Journal of Haematology|January 15, 2019
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survivalAntonio Galleu, Dragana Milojkovic, Simona Deplano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.
Pageof 38

Showing results (361-370 of 374) with videos related to

Sort By:
Pageof 38
Frontiers in Cellular and Infection Microbiology|September 13, 2021
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell TransplantationAndrew J Innes, Benjamin H Mullish, Rohma Ghani, et al.
Bone Marrow Transplantation|April 17, 2021
Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMTToby A Eyre, Sophie Caillard, Herve Finel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2010
Humoral and cellular immunity to primary H1N1 infection in patients with hematologic malignancies following stem cell transplantationPaula Garland, Hugues de Lavallade, Takuya Sekine, et al.
Clinical Genitourinary Cancer|July 23, 2016
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012Andrea Necchi, Salvatore Lo Vullo, Marco Bregni, et al.
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
Blood|April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trialSridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Pharmaceutical Research|January 8, 2014
Current challenges in bioequivalence, quality, and novel assessment technologies for topical productsAvraham Yacobi, Vinod P Shah, Edward D Bashaw, et al.
British Journal of Haematology|January 15, 2019
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survivalAntonio Galleu, Dragana Milojkovic, Simona Deplano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 4, 2014
Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)S Dietrich, A Boumendil, H Finel, et al.
Pageof 38